Quest Partners LLC Krystal Biotech, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 3,020 shares of KRYS stock, worth $567,337. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,020
Previous 1,398
116.02%
Holding current value
$567,337
Previous $254 Million
85.92%
% of portfolio
0.06%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
299Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$742 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$541 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$494 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$240 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$165 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.82B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...